Alterations of mast cells and TGF-β1 on the silymarin treatment for CCl(4)-induced hepatic fibrosis

AIM: Silymarin is a potent antioxidant, antiinflammatory and anti-fibrogenic agent in the liver, which is mediated by alteration of hepatic Kupffer cell function, lipid peroxidation, and collagen production. Especially, in hepatic fibrogenesis, mast cells are expressed in chronic inflammatory condit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World J Gastroenterol
Main Authors: Jeong, Da-Hee, Lee, Gi-Ppeum, Jeong, Won-Il, Do, Sun-Hee, Yang, Hai-Jie, Yuan, Dong-Wei, Park, Ho-Yong, Kim, Kyu-Jong, Jeong, Kyu-Shik
Formato: Artigo
Idioma:Inglês
Publicado em: Baishideng Publishing Group Inc 2005
Assuntos:
Basic Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4250703/
https://ncbi.nlm.nih.gov/pubmed/15754394
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v11.i8.1141
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados